Perpetual Investment Management’s AstraZeneca AZN Stock Holding History

Perpetual Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2.26M	Buy	16,703 +1,500	+10%	+$188K	0.27%	64
2022 Q3	$1.67M	Buy	+15,203	New	+$1.93M	0.24%	73
2022 Q2	–	Sell	-23,137	Closed	-$3.04M	–	69
2022 Q1	$3.07M	Sell	23,137 -3,641	-14%	-$437K	0.39%	68
2021 Q4	$3.12M	Hold	26,778	–	–	0.36%	82
2021 Q3	$3.22M	Buy	26,778 +2,091	+8%	+$243K	0.41%	74
2021 Q2	$2.96M	Buy	24,687 +22,320	+943%	+$2.45M	0.42%	74
2021 Q1	$235K	Buy	+2,367	New	+$238K	0.04%	191

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perpetual Investment Management's AZN Position: Q4 2022 in Review

Perpetual Investment Management increased its AstraZeneca (AZN) stake by 9.9% in Q4 2022, buying an estimated $188K and bringing the position to 16,703 shares worth $2.26M. The position accounts for 0.27% of the portfolio, ranked #64.

Perpetual Investment Management first reported a position in AZN in Q1 2021 and has held it in 7 quarters since. The position peaked at $3.22M in Q3 2021. 1,062 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

Perpetual Investment Management held 16,703 shares of AstraZeneca worth $2.26M as of Q4 2022.
Perpetual Investment Management bought 1,500 AstraZeneca shares in Q4 2022, an estimated $188K.
AstraZeneca made up 0.27% of Perpetual Investment Management's portfolio in Q4 2022, its #64 holding.
Perpetual Investment Management first reported a position in AstraZeneca in Q1 2021 and has held it in 7 quarters since.
Perpetual Investment Management's AstraZeneca position peaked at $3.22M in Q3 2021.
1,062 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Perpetual Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.